GLP-1 receptor agonists and the risk of atrial fibrillation: a real-world evidence

被引：0
|
作者：
Shin, J. I. [1 ]
Xu, Y. [1 ]
Boyle, T. [2 ]
Lyu, B. [1 ]
Ballew, S. [1 ]
Selvin, E. [1 ]
Chang, A. [3 ]
Inker, L. [4 ]
Grams, M. [5 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Epidemiol, Baltimore, MD USA
[2] Univ Penn, Internal Med, Philadelphia, PA USA
[3] Geisinger Commonwealth Sch Med, Internal Med, Scranton, PA USA
[4] Tufts Med Ctr, Internal Med, Boston, MA USA
[5] New York Univ, Grossman Sch Med, Internal Med, New York, NY USA
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2023年 / 197卷
关键词：
D O I：
10.1016/j.diabres.2023.110309
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
IDF2022-04
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
    Seghieri, Marta
    Christensen, Alexander S.
    Andersen, Andreas
    Solini, Anna
    Knop, Filip K.
    Vilsboll, Tina
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [32] Comparative effectiveness and safety of SGLT2 inhibitors vs GLP-1 receptor agonists among real-world older adult
    Patorno, Elisabetta
    Pawar, Ajinkya
    Bessette, Lily G.
    Kim, Dae H.
    Dave, Chintan
    Glynn, Robert J.
    Munshi, Medha N.
    Schneeweiss, Sebastian
    Wexler, Deborah J.
    Kim, Seoyoung C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 109 - 109
  • [33] INSULIN IS MOST APPROPRIATE COMPARATOR TO GLP-1 RECEPTOR AGONISTS AND DPP-4 INHIBITORS IN REAL-WORLD CARDIOVASCULAR OUTCOME STUDIES
    Ali, A. K.
    Motsko, S. P.
    VALUE IN HEALTH, 2017, 20 (05) : A311 - A311
  • [34] Real-World Effectiveness of SGLT2 Inhibitors vs. GLP-1 Receptor Agonists in Patients With and Without Cardiovascular Disease
    Patorno, Elisabetta
    Pawar, Ajinkya
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Kim, Dae H.
    Everett, Brendan M.
    Bessette, Lily G.
    Kim, Seoyoung C.
    DIABETES, 2019, 68
  • [35] GLP-1 receptor agonists increase risk of being dispensed antidepressants
    Reactions Weekly, 2024, 2009 (1) : 8 - 8
  • [36] GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk
    Liuzzo, Giovanna
    Galiuto, Leonarda
    EUROPEAN HEART JOURNAL, 2021, 42 (17) : 1652 - 1653
  • [37] The effect of GLP-1 receptor agonists on targets for cardiovascular risk reduction
    Westrick, Christopher
    Snider, Melissa
    Arradaza, Nicole
    Sharma, Kavita
    PHARMACOTHERAPY, 2013, 33 (10): : E190 - E190
  • [38] Preoperative GLP-1 Receptor Agonists and Risk of Postoperative Respiratory Complications
    Milder, David A.
    Milder, Tamara Y.
    Kam, Peter
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (02):
  • [39] The Cardiovascular Effects of GLP-1 Receptor Agonists
    Okerson, Theodore
    Chilton, Robert J.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e146 - e155
  • [40] GLP-1 receptor agonists in heart failure
    Vaduganathan, Muthiah
    LANCET, 2024, 404 (10454): : 727 - 729
12345